NCT01989013
Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
Enrolling by Invitation
NAAges 18+InterventionalTreatmentZia, Al RazaInvestigator-initiated
~5 participants
Updated 2025-01-22 on ClinicalTrials.gov
What's tested:biweekly intervention
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
reduction in tremors due to Parkinson's disease in the patient
Measured over 3 months
Conditions
Where it's being run
1 sites across 1 statesMichigan1
Study leadership
- Al Raza, CST · PRINCIPAL_INVESTIGATOR · IBR, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
must be Diagnosed with Parkinson's Disease
Exclusion
Anyone without Parkinson's Disease
What this trial measures
- reduction in tremors due to Parkinson's disease in the patient3 months
Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction